UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail

PloS one, 2013-07, Vol.8 (7), p.e69593-e69593

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting Wnt pathways in disease

Cold Spring Harbor perspectives in biology, 2012-11, Vol.4 (11), p.a008086-a008086

2012

Link zum Volltext

Verfügbarkeit prüfen

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration

European journal of cancer (1990), 2021-11, Vol.157, p.198-213

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective

Journal of medical economics, 2017-09, Vol.20 (9), p.911-922

2017

Link zum Volltext

Verfügbarkeit prüfen

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

European journal of cancer (1990), 2021-11, Vol.157, p.198-213

2021

Link zum Volltext

Verfügbarkeit prüfen

Maintenance Therapy with Blinatumomab in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL): Overall Survival in Adults Enrolled in a Phase 3 Open-Label Trial

Blood, 2017-12, Vol.130, p.2552-2552

2017

Link zum Volltext

Verfügbarkeit prüfen

Disease Burden Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER)

Blood, 2018-11, Vol.132 (Supplement 1), p.3967-3967

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Study of Blinatumomab in Japanese Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Blood, 2018-11, Vol.132 (Supplement 1), p.5167-5167

2018

Link zum Volltext

Verfügbarkeit prüfen

Age Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label, Phase 3 Study (TOWER)

Blood, 2018-11, Vol.132 (Supplement 1), p.5165-5165

2018

Link zum Volltext

Verfügbarkeit prüfen

Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study

Blood, 2017-12, Vol.130, p.2556-2556

2017

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life in Adults Treated with Blinatumomab Using the Acute Lymphoblastic Leukemia Symptom Scale

Blood, 2017-12, Vol.130, p.2571-2571

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract B66: Activation of Wnt/β-catenin signaling enhances TRAIL-dependent apoptosis in human melanoma

Clinical cancer research, 2012-05, Vol.18 (10_Supplement), p.B66-B66

2012

Link zum Volltext

Verfügbarkeit prüfen

Both Recipient TNaive and TMemory Cells Mediate Efficient Resistance Against Marrow Allografts in the Absence of Major Cytotoxic Effector Pathways

Blood, 2004-11, Vol.104 (11), p.2130-2130

2004

Link zum Volltext

Verfügbarkeit prüfen

Donor Antigen Presenting Cell CD80/86 Function Is Required for Eliciting T Cell Resistance Against Progenitor Cell Engraftment in an MHC Matched Allogeneic Non-Myeloablative Transplantation Model

Blood, 2004-11, Vol.104 (11), p.2137-2137

2004

Link zum Volltext

Verfügbarkeit prüfen

Memory Effector Cells but Not Effector Cells Derived from Naive T Cells Can Utilize a Non-Perforin and Non-FasL Pathway To Inhibit Allogeneic Progenitor Cell Function Ex-Vivo

Blood, 2005-11, Vol.106 (11), p.3029-3029

2005

Link zum Volltext

Verfügbarkeit prüfen

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Nature microbiology, 2022-06, Vol.7 (6), p.766

2022

Link zum Volltext

Verfügbarkeit prüfen

Self-organizing behaviors of cardiovascular cells on synthetic nanofiber scaffolds

APL bioengineering, 2023-12, Vol.7 (4), p.046114-046114

2023

Link zum Volltext

Verfügbarkeit prüfen

Handbook of psychological pediatric screening and assessment in primary care

Maruish, Mark E

1st, 2018

Link zum Volltext

Verfügbarkeit prüfen

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

Muscle & nerve, 2008-07, Vol.38 (1), p.837-844

2008

Link zum Volltext

Verfügbarkeit prüfen

Accessible Public Transportation: Designing Service for Riders with Disabilities

1st edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

Distributed management of flexible times schedules

Proceedings of the 6th international joint conference on autonomous agents and multiagent systems, 2007, p.1-8

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Humans
(6)
Life Sciences & Biomedicine
(6)
Drug Development
(3)
Aged
(2)
Anaplastic Lymphoma Kinase Inhibition
(2)
Beta Catenin - Metabolism
(2)
Cancer Therapeutics
(2)
Cell Biology
(2)
Children
(2)
Engineering
(2)
Female
(2)
Kinases
(2)
Male
(2)
Middle Aged
(2)
Neoplasms - Drug Therapy
(2)
Paediatric Oncology
(2)
Paediatric Strategy Forum
(2)
Protein Kinase Inhibitors - Pharmacology
(2)
Technology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(9)
European Journal Of Cancer
(2)
Apl Bioengineering
(1)
Clinical Cancer Research
(1)
Cold Spring Harbor Perspectives In Biology
(1)
Journal Of Medical Economics
(1)
Muscle & Nerve
(1)
Nature Microbiology
(1)
Plos One
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail

Targeting Wnt pathways in disease

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration

Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

Maintenance Therapy with Blinatumomab in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL): Overall Survival in Adults Enrolled in a Phase 3 Open-Label Trial

Disease Burden Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER)

Phase 2 Study of Blinatumomab in Japanese Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Age Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label, Phase 3 Study (TOWER)

Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study

Health-Related Quality of Life in Adults Treated with Blinatumomab Using the Acute Lymphoblastic Leukemia Symptom Scale

Abstract B66: Activation of Wnt/β-catenin signaling enhances TRAIL-dependent apoptosis in human melanoma

Both Recipient TNaive and TMemory Cells Mediate Efficient Resistance Against Marrow Allografts in the Absence of Major Cytotoxic Effector Pathways

Donor Antigen Presenting Cell CD80/86 Function Is Required for Eliciting T Cell Resistance Against Progenitor Cell Engraftment in an MHC Matched Allogeneic Non-Myeloablative Transplantation Model

Memory Effector Cells but Not Effector Cells Derived from Naive T Cells Can Utilize a Non-Perforin and Non-FasL Pathway To Inhibit Allogeneic Progenitor Cell Function Ex-Vivo

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Self-organizing behaviors of cardiovascular cells on synthetic nanofiber scaffolds

Handbook of psychological pediatric screening and assessment in primary care

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

Accessible Public Transportation: Designing Service for Riders with Disabilities

Distributed management of flexible times schedules

Suchergebnisse filtern